GSK PLC (GSK)
44.14
-0.01
(-0.02%)
USD |
NYSE |
May 08, 16:00
44.48
+0.34
(+0.77%)
Pre-Market: 08:37
GSK Price: 44.14 for May 8, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 08, 2024 | 44.23 | 44.29 | 44.06 | 44.14 | 2.039M |
| May 07, 2024 | 44.13 | 44.33 | 43.96 | 44.15 | 3.104M |
| May 06, 2024 | 43.50 | 43.64 | 43.18 | 43.45 | 2.046M |
| May 03, 2024 | 43.58 | 43.68 | 43.27 | 43.50 | 4.048M |
| May 02, 2024 | 42.90 | 43.52 | 42.75 | 43.35 | 6.320M |
| May 01, 2024 | 42.70 | 42.84 | 42.28 | 42.57 | 4.686M |
| Apr 30, 2024 | 41.75 | 42.03 | 41.42 | 41.44 | 3.672M |
| Apr 29, 2024 | 41.66 | 42.00 | 41.50 | 41.61 | 4.242M |
| Apr 26, 2024 | 40.95 | 41.31 | 40.87 | 41.11 | 2.730M |
| Apr 25, 2024 | 41.06 | 41.11 | 40.80 | 40.91 | 3.462M |
| Apr 24, 2024 | 41.20 | 41.24 | 40.64 | 40.86 | 1.816M |
| Apr 23, 2024 | 40.66 | 41.26 | 40.60 | 41.24 | 2.290M |
| Apr 22, 2024 | 39.99 | 40.76 | 39.96 | 40.59 | 3.801M |
| Apr 19, 2024 | 39.37 | 39.76 | 39.37 | 39.75 | 1.624M |
| Apr 18, 2024 | 39.39 | 39.50 | 39.16 | 39.27 | 2.637M |
| Apr 17, 2024 | 39.72 | 39.85 | 39.44 | 39.60 | 3.208M |
| Apr 16, 2024 | 40.02 | 40.23 | 39.72 | 39.95 | 2.423M |
| Apr 15, 2024 | 40.90 | 41.06 | 40.44 | 40.50 | 3.374M |
| Apr 12, 2024 | 40.96 | 40.97 | 40.49 | 40.66 | 5.265M |
| Apr 11, 2024 | 41.00 | 41.25 | 40.68 | 40.80 | 2.904M |
| Apr 10, 2024 | 40.62 | 40.75 | 40.48 | 40.69 | 4.370M |
| Apr 09, 2024 | 40.89 | 40.96 | 40.67 | 40.88 | 3.191M |
| Apr 08, 2024 | 41.08 | 41.08 | 40.82 | 40.85 | 1.856M |
| Apr 05, 2024 | 40.59 | 41.25 | 40.54 | 41.19 | 6.093M |
| Apr 04, 2024 | 41.73 | 41.88 | 40.84 | 40.86 | 2.634M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
28.66
Minimum
Sep 27 2022
58.56
Maximum
Apr 13 2022
40.81
Average
40.16
Median
May 20 2019
Price Benchmarks
| AstraZeneca PLC | 76.97 |
| Novo Nordisk A/S | 126.69 |
| Pfizer Inc | 28.27 |
| Sanofi SA | 50.10 |
| Moderna Inc | 121.89 |
Price Related Metrics
| PE Ratio | 17.30 |
| PS Ratio | 2.493 |
| Price to Book Value | 5.151 |
| Price to Free Cash Flow | 14.63 |
| Earnings Yield | 5.78% |
| Market Cap | 90.00B |
| Operating PE Ratio | 11.34 |
| Normalized PE Ratio | 15.67 |